Skip to main content
Equibles
DCGO logo

DCGO · DocGo Inc. · Metrics

Track DCGO — free

Use DCGO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DCGO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.37 -0.02 (-4.64%) At close · Sep 9
Rebalance outlook locked
Going-concern doubt — cleared Aug 17, 2026

The latest filing states the doubt was alleviated.

“While these plans carry meaningful inherent risk to operations and involve a significant number of steps and components, the Company's management and the Board of Directors have evaluated these conditions in totality and believe it is probable that, when implemented, the plans will be sufficient to alleviate substantial doubt about the Company's ability to continue as a going concern for the twelve months following the issuance date.”
View the 10-Q filed Aug 17, 2026
Market Cap
$38.38M
Shares
98.93M

DCGO metrics

79 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.37
Market cap
$38.38M

Price action

20 metrics
Price change (1W)
+0.6%
Price change (30D)
-32.5%
Price change (3M)
-33.0%
Price change (6M)
-39.8%
Price change (YTD)
-55.8%
Price change (1Y)
-75.3%
Trailing year
Price change (5Y)
-96.1%
52-week high
$1.58
52-week low
$0.38
Change from 52-week high
-75.4%
Change from 52-week low
+1.8%
Annualized volatility
87.2%
Annualized volatility (3M)
105.8%
Beta
1.7
RSI (14D)
35.2
Price vs SMA 50
-30.5%
Price vs SMA 200
-43.6%
Avg volume (3M)
924,519
Relative volume
0.4
Average dollar volume
$478,665

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
98.93M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.0×
reciprocal yield 2,206.3%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.1×
reciprocal yield 767.8%
P / book
0.3
reciprocal yield 310.2%
FCF yield
-67.3%
TTM · current market cap
Buyback yield
0.0%
P / FCF
—
P / operating cash flow
—
Earnings yield
-501.3%

Historical valuation

8 metrics
P / E historical average (3Y)
22.2×
reciprocal yield 4.5%
P / E historical average (5Y)
22.2×
reciprocal yield 4.5%
EV / revenue historical average (3Y)
0.3×
reciprocal yield 300.8%
EV / revenue historical average (5Y)
0.5×
reciprocal yield 213.1%
EV / EBIT historical average (3Y)
35.5×
reciprocal yield 2.8%
EV / EBIT historical average (5Y)
35.5×
reciprocal yield 2.8%
EV / EBITDA historical average (3Y)
18.3×
reciprocal yield 5.5%
EV / EBITDA historical average (5Y)
18.3×
reciprocal yield 5.5%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-17

Profitability

9 metrics
Gross margin
—
Operating margin
-62.2%
Trailing 12 months
Net margin
-65.3%
Gross profit (TTM)
—
Operating profit (TTM)
−$183.19M
Net income (TTM)
−$192.42M
Trailing 12 months
Diluted EPS (TTM)
$-1.95
FCF margin
-8.8%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$1.46

Growth

11 metrics
Revenue growth YoY
-8.7%
Year over year
Net income growth YoY
-1,012.4%
Revenue (TTM)
$294.72M
Trailing 12 months
EPS growth YoY
-1,122.2%
Shares change YoY
-0.1%
Year over year · fewer shares
Revenue CAGR (3Y)
-9.9%
Revenue CAGR (5Y)
+27.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+5.2%
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-161.6%
Return on assets
-103.0%
Debt / equity
0.0
Current ratio
1.7
EBITDA (TTM)
−$169.93M
Free cash flow (TTM)
−$25.83M
Quick ratio
1.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$25.03M
Latest balance sheet
Cash & equivalents
$25.23M
Total assets
$186.82M
Total debt
$207,373

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$22.71M
Capital expenditures (TTM)
$3.12M
R&D (TTM)
$14.12M
SG&A (TTM)
—
Stock compensation (TTM)
$13.67M
R&D / revenue
4.8%
Stock compensation / revenue
4.6%

Ownership (13F)

3 metrics
13F filers
120
13F filer change QoQ
-3
Institutional ownership
38.5%

Short interest

3 metrics
Short interest
2.2%
Latest settlement · 5.2 days to cover
Days to cover
5.2d
Short-squeeze score
47 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1822359 CUSIP 256086109 13F (30d) 83 filings 83 filers Visit website Investor relations